Breaking News Instant updates and real-time market news.

SHPG

Shire

$194.59

-0.85 (-0.43%)

15:50
10/05/16
10/05
15:50
10/05/16
15:50

Bass group denied request for review of Shire patent claims

The Coalition For Affordable Drugs, a group linked to Hayman Capital's Kyle Bass, was denied its request for the institution of an "inter partes review" of claims 1-4 of U.S. Patent No. 6,773,720, which is held by Cosmo Technologies. There are related district court proceedings regarding the '720 patent in which Shire (SHPG) is involved, the decision posted to the USPTO site states.

SHPG Shire
$194.59

-0.85 (-0.43%)

08/03/16
LEER
08/03/16
NO CHANGE
Target $231
LEER
Outperform
Shire price target raised to $231 from $213 at Leerink
Leerink analyst Jason Gerberry raised his price target for Shire to $231 from $213 on valuation after the company reported "solid" Q2 results. The analyst reiterates an Outperform rating on the shares.
08/31/16
JEFF
08/31/16
NO CHANGE
Target $262
JEFF
Buy
Shire making right moves in dry eye market, says Jefferies
After hosting meetings with management, Jefferies analyst David Steinberg believes Shire (SHPG) is making "all the right moves" to make its dry eye drug Xiidra a potential $2B peak product in the U.S. Shire's Xiidra is competing with Allergan's (AGN) $1.4B dry eye drug Restasis, Steinberg tells investors in a research note. The analyst does not think Shire will have any problem exceeding the drug's consensus sales forecast of $200M for next year. He keeps a Buy rating on the shares with a $262 price target.
09/26/16
HSBC
09/26/16
DOWNGRADE
HSBC
Hold
Shire downgraded to Hold from Buy at HSBC
HSBC analyst Steve McGarry downgraded SHire to Hold saying valuation is no longer compelling.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.

TODAY'S FREE FLY STORIES

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

, VRX

Valeant

$15.42

0.335 (2.22%)

13:06
12/08/16
12/08
13:06
12/08/16
13:06
Hot Stocks
Express Scripts drops after Citron compares to Valeant's Philidor »

Shares of Express Scripts…

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

VRX

Valeant

$15.42

0.335 (2.22%)

CVS

CVS Health

$79.80

-0.73 (-0.91%)

WBA

Walgreens Boots Alliance

$84.99

0.28 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 15

    Dec

  • 05

    Jan

  • 16

    Feb

YY

YY

$41.00

0.44 (1.08%)

13:05
12/08/16
12/08
13:05
12/08/16
13:05
Options
YY call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$26.39

7.4597 (39.41%)

13:02
12/08/16
12/08
13:02
12/08/16
13:02
Hot Stocks
Tailored Brands surges as Jos. A. Bank turnaround gains traction »

Shares of Tailored Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

GE

General Electric

$31.68

0.08 (0.25%)

13:01
12/08/16
12/08
13:01
12/08/16
13:01
Hot Stocks
GE Transportation acquires Iders Incorporated, terms not disclosed »

GE Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

13:01
12/08/16
12/08
13:01
12/08/16
13:01
Periodicals
Citron cautious on Express Scripts, has $45 target on shares »

Citron Research tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSY

Insys Therapeutics

$10.70

-0.54 (-4.80%)

12:57
12/08/16
12/08
12:57
12/08/16
12:57
Hot Stocks
Justice Department arrests former Insys executives, including CEO »

The U.S. Attorney's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBOT

Microbot Medical

$7.75

-0.3 (-3.73%)

12:56
12/08/16
12/08
12:56
12/08/16
12:56
Hot Stocks
Breaking Hot Stocks news story on Microbot Medical »

Greenblock Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

12:53
12/08/16
12/08
12:53
12/08/16
12:53
Recommendations
Horizon Pharma analyst commentary  »

BMO cuts Horizon Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 14

    Dec

MLSS

Milestone Scientific

$1.77

-0.3254 (-15.50%)

12:51
12/08/16
12/08
12:51
12/08/16
12:51
Hot Stocks
Milestone Scientific: Henry Schein ahead of schedule in The Wand training »

Milestone Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:44
12/08/16
12/08
12:44
12/08/16
12:44
Hot Stocks
Breaking Hot Stocks news story on Universal Technical »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FEYE

FireEye

$13.61

0.41 (3.11%)

12:40
12/08/16
12/08
12:40
12/08/16
12:40
Options
FireEye calls active »

FireEye calls active. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

12:40
12/08/16
12/08
12:40
12/08/16
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:38
12/08/16
12/08
12:38
12/08/16
12:38
Hot Stocks
Breaking Hot Stocks news story on Universal Technical »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:38
12/08/16
12/08
12:38
12/08/16
12:38
Hot Stocks
Breaking Hot Stocks news story on Universal Technical »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$44.47

0.1 (0.23%)

12:35
12/08/16
12/08
12:35
12/08/16
12:35
Options
Monster Beverage put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PF

Pinnacle Foods

$51.04

0.58 (1.15%)

12:31
12/08/16
12/08
12:31
12/08/16
12:31
Conference/Events
Pinnacle Foods to hold an investor luncheon »

Investor Luncheon where…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:30
12/08/16
12/08
12:30
12/08/16
12:30
Hot Stocks
Universal Technical: No pending non-public disclosures to account for stock rise »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
12/08/16
12/08
12:30
12/08/16
12:30
General news
U.S. Household net worth rose »

U.S. Household net worth…

SAN

Banco Santander

$5.19

0.1549 (3.07%)

12:25
12/08/16
12/08
12:25
12/08/16
12:25
Options
Banco Santander call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
12/08/16
12/08
12:25
12/08/16
12:25
Conference/Events
Wells Fargo economists hold an analyst/industry conference call »

Chief Economist Silvia,…

TWTR

Twitter

$19.34

-0.14 (-0.72%)

12:21
12/08/16
12/08
12:21
12/08/16
12:21
Periodicals
Spotify cancels talks to acquire SoundCloud, TechCrunch says »

Spotify has pulled out of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$4.15

0.042 (1.02%)

12:17
12/08/16
12/08
12:17
12/08/16
12:17
Hot Stocks
Fujian Grand Chip cancels Aixtron takeover bid after U.S. intervention »

Grand Chip Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/08/16
12/08
12:16
12/08/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/08/16
12/08
12:16
12/08/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is lighter for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$114.46

1.79 (1.59%)

12:15
12/08/16
12/08
12:15
12/08/16
12:15
Options
PNC Financial put volume heavy and directionally bearish »

Bearish flow noted in PNC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.